Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma
DE Kang, RL White Jr, JH Zuger, HC Sasser… - The Journal of …, 2004 - Elsevier
PURPOSE: We evaluate the role of fluorodeoxyglucose F 18 positron emission tomography
(PET) in patients with renal cell carcinoma (RCC) by retrospective review. To our knowledge
this series is the largest reviewing the use of PET in patients with RCC. MATERIALS AND
METHODS: A total of 66 patients who underwent 90 PET scans for suspected or known RCC
were identified. Dictated reports of PET, chest computerized tomography (CT),
abdominal/pelvic CT and bone scan were examined with confirmation of results by …
(PET) in patients with renal cell carcinoma (RCC) by retrospective review. To our knowledge
this series is the largest reviewing the use of PET in patients with RCC. MATERIALS AND
METHODS: A total of 66 patients who underwent 90 PET scans for suspected or known RCC
were identified. Dictated reports of PET, chest computerized tomography (CT),
abdominal/pelvic CT and bone scan were examined with confirmation of results by …